Profiel
Ingrid Goldberg is currently Vice President-Investor Relations at Medtronic Plc since 2025.
Former roles include Director-Investor Relations at ABIOMED, Inc. from 2014 to 2019, Vice President-Investor Relations at bluebird bio, Inc. from 2020 to 2021, and Vice President-Finance & Investor Relations at NovoCure Ltd. Education includes undergraduate studies at Princeton University and an MBA from MIT Sloan School of Management.
Actieve functies van Ingrid Goldberg
| Bedrijven | Functie | Begin |
|---|---|---|
| MEDTRONIC PLC | Investor Relations Contact | 08-12-2025 |
Eerdere bekende functies van Ingrid Goldberg
| Bedrijven | Functie | Einde |
|---|---|---|
| GENETIX BIOTHERAPEUTICS, INC. | Investor Relations Contact | 01-06-2021 |
| ABIOMED, INC. | Investor Relations Contact | 01-12-2019 |
| NOVOCURE LIMITED | Investor Relations Contact | - |
Opleiding van Ingrid Goldberg
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
ABIOMED, Inc.
ABIOMED, Inc. Medical SpecialtiesHealth Technology Manufactures cardiac support, recovery and replacement devices | Health Technology |
bluebird bio, Inc.
bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NovoCure Ltd.
NovoCure Ltd. Medical SpecialtiesHealth Technology Operates as a commercial-stage oncology company | Health Technology |
MIT Sloan School of Management
MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medtronic Plc
Medtronic Plc Medical SpecialtiesHealth Technology Provides medical technology services | Health Technology |
















